Publications by authors named "Michelle C Fox"

Claim this Profile
D
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial.
Jürgen K Rockstroh, Roger Paredes, Pedro Cahn, Jean-Michel Molina, Simiso M Sokhela, Michelle C Fox

Clin Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial.
Jean-Michel Molina, Giuliano Rizzardini, Catherine Orrell, Alejandro Afani, Alexandra Calmy, Michelle C Fox

Lancet HIV· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.
Anthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, Olayemi O Osiyemi, Johannes R Bogner, Michelle C Fox

Lancet HIV· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism.
R Ravi Shankar, Suneri Shah, Hee-Koung Joeng, Geraldine Mendizabal, Julia R DiBello, Michelle C Fox

J Clin Endocrinol Metab· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurovascular anatomy of the adult female medial arm in relationship to potential sites for insertion of the etonogestrel contraceptive implant.
Joe Iwanaga, Michelle C Fox, Hans Rekers, Lisa Schwartz, R Shane Tubbs

Contraception· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.
Michelle C Fox, Christine Klipping, Allison Martin Nguyen, Tara L Frenkl, Sandra M Cruz

Contraception· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.
Robert Feldman, Tara L Frenkl, Carol Yacik, Yinna Wang, Michelle C Fox

Contraception· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
Irene Woo, Sara Seifert, Dacia Hendricks, Roxanne M Jamshidi, Anne E Burke, Michelle C Fox

Contraception· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4.
Michelle C Fox, Colleen M Krajewski

Contraception· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical problem-solving. A patient with syncope.
Michelle C Fox, Neal Lakdawala, Amy Leigh Miller, Joseph Loscalzo

N Engl J Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactive medical case. A patient with syncope.
Michelle C Fox, Monica Sircar, Anand Vaidya, Joel T Katz, Neal Lakdawala

N Engl J Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate placement of intrauterine devices after first and second trimester pregnancy termination.
Michelle C Fox, Julia Oat-Judge, Kathryn Severson, Roxanne M Jamshidi, Rameet H Singh

Contraception· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA miR-125a controls hematopoietic stem cell number.
Shangqin Guo, Jun Lu, Rita Schlanger, Hao Zhang, Judy Y Wang, Michelle C Fox

Proc Natl Acad Sci U S A· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postexposure prophylaxis for victims of sexual assault: treatments and attitudes of emergency department physicians.
Arvind Bakhru, Julie B Mallinger, Michelle C Fox

Contraception· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical dilation in second-trimester abortion.
Jennifer L Hayes, Michelle C Fox

Clin Obstet Gynecol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation.
Michelle C Fox, Jennifer L Hayes,

Contraception· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.
Mitchell D Creinin, Michelle C Fox, Stephanie Teal, Angela Chen, Eric A Schaff

Obstet Gynecol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of the use of a daily electronic mail reminder to improve oral contraceptive compliance.
Michelle C Fox, Mitchell D Creinin, Amitasrigowri S Murthy, Bryna Harwood, Lynn M Reid

Contraception· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
Michelle C Fox, Mitchell D Creinin, Bryna Harwood

Contraception· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early surgical abortion: efficacy and safety.
Maureen E Paul, Caroline M Mitchell, Angela J Rogers, Michelle C Fox, Elyse G Lackie

Am J Obstet Gynecol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis